Chengyang Song's research while affiliated with First Affiliated Hospital of China Medical University and other places

Publications (2)

Article
Full-text available
Osimertinib is a third-generation, irreversible mutant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that is approved by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA). Osimertinib is currently the first line drug recommended by National Comprehensive Cancer Network (NCCN) guidelines against lung...
Article
Full-text available
The lung tumor microenvironment, which is composed of heterogeneous cell populations, plays an important role in the progression of lung cancer and is closely related to therapeutic efficacy. Increasing evidence has shown that stromal components play a key role in regulating tumor invasion, metastasis and drug resistance. Therefore, a better unders...

Citations

... Library construction and data analysis of bulk and single-cell sequencing approaches share essentially the same principles and workflows [60]. ...